Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Wintrust Financial
WTFC
$10.3B
| $26.8M | 0.04% |
342,182
+257,615
| +305% | +$19.1M |
|
627
Petrobras
PBR
$120B
| $26.8M | 0.04% |
2,666,113
-993,702
| -27% | -$9.02M |
|
628
Graphic Packaging
GPK
$3.41B
| $26.8M | 0.04% |
1,918,575
+1,082,589
| +129% | +$14.5M |
|
629
Ingevity
NGVT
$2.38B
| $26.7M | 0.04% |
427,905
+271,254
| +173% | +$16.1M |
|
630
BHP
BHP
$247B
| $26.7M | 0.04% |
+739,119
| New | +$27M |
|
631
Oneok
OKE
$58.7B
| $26.7M | 0.04% |
482,018
-980,029
| -67% | -$53M |
|
|
BPFH
632
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $26.7M | 0.04% |
1,613,783
+449,178
| +39% | +$6.79M |
|
|
ADMS
633
DELISTED
Adamas Pharmaceuticals
ADMS
| $26.7M | 0.04% |
1,260,579
+923,203
| +274% | +$16.9M |
|
634
CALL
AbbVie
ABBV
$466B
| $26.7M | 0.04% |
+300,000
| New | +$22.8M |
|
635
Amphenol
APH
$192B
| $26.6M | 0.04% |
1,257,508
+844,516
| +204% | +$16.6M |
|
636
Palo Alto Networks
PANW
$286B
| $26.6M | 0.04% |
1,105,974
+183,186
| +20% | +$4.17M |
|
|
BIVV
637
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $26.6M | 0.04% |
465,430
+449,470
| +2,816% | +$26.3M |
|
638
Coty
COTY
$2.46B
| $26.5M | 0.04% |
1,603,995
+1,062,717
| +196% | +$19.2M |
|
|
BKI
639
DELISTED
Black Knight, Inc. Common Stock
BKI
| $26.5M | 0.04% |
615,127
-58,302
| -9% | -$2.47M |
|
640
Piper Sandler
PIPR
$5.28B
| $26.4M | 0.04% |
1,782,140
+231,384
| +15% | +$3.41M |
|
|
PX
641
DELISTED
Praxair Inc
PX
| $26.4M | 0.04% |
188,980
+18,860
| +11% | +$2.51M |
|
|
GRA
642
DELISTED
W.R. Grace & Co.
GRA
| $26.4M | 0.04% |
365,255
-152,664
| -29% | -$10.8M |
|
|
WLH
643
DELISTED
WILLIAM LYON HOMES
WLH
| $26.3M | 0.04% |
+1,143,961
| New | +$26.6M |
|
644
Mettler-Toledo International
MTD
$28.2B
| $26.3M | 0.04% |
41,931
+25,409
| +154% | +$15.3M |
|
645
Roper Technologies
ROP
$41.1B
| $26.2M | 0.04% |
107,730
+104,404
| +3,139% | +$24.5M |
|
|
HI
646
DELISTED
Hillenbrand
HI
| $26.2M | 0.04% |
674,327
+383,423
| +132% | +$13.9M |
|
647
PepsiCo
PEP
$197B
| $26.2M | 0.04% |
234,968
-446,369
| -66% | -$51.6M |
|
648
Emergent Biosolutions
EBS
$264M
| $26M | 0.04% |
643,163
+125,603
| +24% | +$4.54M |
|
|
OPLN
649
Openlane
OPLN
$4.16B
| $25.9M | 0.04% |
1,430,857
-1,592,236
| -53% | -$26.3M |
|
650
Vanda Pharmaceuticals
VNDA
$322M
| $25.8M | 0.04% |
1,440,761
+1,006,282
| +232% | +$16.8M |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.